SG11202009773VA - Heterotandem bicyclic peptide complexes - Google Patents
Heterotandem bicyclic peptide complexesInfo
- Publication number
- SG11202009773VA SG11202009773VA SG11202009773VA SG11202009773VA SG11202009773VA SG 11202009773V A SG11202009773V A SG 11202009773VA SG 11202009773V A SG11202009773V A SG 11202009773VA SG 11202009773V A SG11202009773V A SG 11202009773VA SG 11202009773V A SG11202009773V A SG 11202009773VA
- Authority
- SG
- Singapore
- Prior art keywords
- peptide complexes
- bicyclic peptide
- heterotandem bicyclic
- heterotandem
- complexes
- Prior art date
Links
- 125000002619 bicyclic group Chemical group 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1805492.4A GB201805492D0 (en) | 2018-04-04 | 2018-04-04 | Heterotandem Bicyclic peptide complexes |
| GBGB1820981.7A GB201820981D0 (en) | 2018-12-21 | 2018-12-21 | Heterotandem bicyclic peptide complexes |
| PCT/GB2019/050951 WO2019193328A1 (en) | 2018-04-04 | 2019-04-02 | Heterotandem bicyclic peptide complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009773VA true SG11202009773VA (en) | 2020-10-29 |
Family
ID=66175434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009773VA SG11202009773VA (en) | 2018-04-04 | 2019-04-02 | Heterotandem bicyclic peptide complexes |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11453703B2 (en) |
| EP (1) | EP3774851A1 (en) |
| JP (2) | JP2021520378A (en) |
| KR (1) | KR20200139236A (en) |
| CN (1) | CN112236442A (en) |
| AU (1) | AU2019247795A1 (en) |
| BR (1) | BR112020020349A2 (en) |
| CA (1) | CA3095582A1 (en) |
| IL (1) | IL277717A (en) |
| MX (1) | MX2020010444A (en) |
| SG (1) | SG11202009773VA (en) |
| WO (1) | WO2019193328A1 (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201607827D0 (en) | 2016-05-04 | 2016-06-15 | Bicycle Therapeutics Ltd | Bicyclic peptide-toxin conjugates specific for MT1-MMP |
| CN110603261A (en) | 2016-12-23 | 2019-12-20 | 拜斯科阿迪有限公司 | Peptide derivatives having novel bond structure |
| CN111032678A (en) | 2017-06-26 | 2020-04-17 | 拜西克尔德有限公司 | Bicyclic peptide ligands with detectable moieties and uses thereof |
| EP3661948B1 (en) | 2017-08-04 | 2022-06-01 | BicycleTx Limited | Bicyclic peptide ligands specific for cd137 |
| TWI825046B (en) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Bicyclic peptide ligands specific for epha2 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| BR112020014576A2 (en) | 2018-02-23 | 2020-12-08 | Bicycletx Limited | MULTIMERIC BICYCLIC PEPTIDE BINDERS |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| US11180531B2 (en) * | 2018-06-22 | 2021-11-23 | Bicycletx Limited | Bicyclic peptide ligands specific for Nectin-4 |
| WO2020128527A1 (en) * | 2018-12-21 | 2020-06-25 | Bicyclerd Limited | Bicyclic peptide ligands specific for pd-l1 |
| CN113474045A (en) * | 2018-12-21 | 2021-10-01 | 拜斯科技术开发有限公司 | PD-L1 specific bicyclic peptide ligands |
| BR112021022315A2 (en) | 2019-05-09 | 2021-12-28 | Bicycletx Ltd | Ox40-specific bicyclic peptide ligands |
| TW202110485A (en) | 2019-07-30 | 2021-03-16 | 英商拜西可泰克斯有限公司 | Heterotandem bicyclic peptide complex |
| WO2021028686A1 (en) * | 2019-08-13 | 2021-02-18 | Bicycletx Limited | Modified multimeric bicyclic peptide ligands |
| WO2021064428A1 (en) * | 2019-10-03 | 2021-04-08 | Bicycletx Limited | Heterotandem bicyclic peptide complexes |
| GB201914872D0 (en) * | 2019-10-15 | 2019-11-27 | Bicycletx Ltd | Bicyclic peptide ligand drug conjugates |
| AU2021327130A1 (en) | 2020-08-17 | 2023-03-02 | Bicycletx Limited | Bicycle conjugates specific for Nectin-4 and uses thereof |
| GB202016331D0 (en) * | 2020-10-15 | 2020-12-02 | Bicyclerd Ltd | Bicyclic peptide ligand drug conjugates |
| KR20230141794A (en) * | 2021-01-08 | 2023-10-10 | 바이사이클티엑스 리미티드 | Heterotandem bicyclic peptide complex |
| EP4274597A1 (en) | 2021-01-11 | 2023-11-15 | BicycleTX Limited | Methods for treating cancer |
| WO2022253051A1 (en) * | 2021-06-01 | 2022-12-08 | 南京明德新药研发有限公司 | Polypeptide conjugated drug and use thereof |
| CA3228897A1 (en) * | 2021-08-17 | 2023-02-23 | Medshine Discovery Inc. | Polypeptide drug conjugate having novel structure and application thereof |
| TWI803993B (en) * | 2021-09-28 | 2023-06-01 | 廖嘉鴻 | Cyclic peptide self-assembled 3d microparticle device and manufacturing method thereof |
| WO2023051396A1 (en) * | 2021-09-29 | 2023-04-06 | 南京明德新药研发有限公司 | Tricyclic polypeptide conjugated drug and use thereof |
| CN115819618B (en) * | 2022-09-16 | 2023-10-27 | 哈尔滨工业大学 | Photo-activated nano-anti-conjugate dimerization inducer PANCID and application thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| PT1844337E (en) | 2005-01-24 | 2014-04-03 | Pepscan Systems Bv | Binding compounds, immunogenic compounds and peptidomimetics |
| EP2653543A1 (en) | 2008-02-05 | 2013-10-23 | Bicycle Therapeutics Limited | Methods and Compositions |
| GB0913775D0 (en) * | 2009-08-06 | 2009-09-16 | Medical Res Council | Multispecific peptides |
| JP2013518807A (en) * | 2010-02-04 | 2013-05-23 | メディカル リサーチ カウンシル | Multispecific peptide |
| CN103906865B (en) * | 2011-10-07 | 2017-12-08 | 拜斯科医疗有限公司 | The regulation and control of structuring polypeptid specificity |
| US20140274759A1 (en) * | 2013-03-15 | 2014-09-18 | Bicycle Therapeutics Limited | Modification of polypeptides |
| PT3215518T (en) * | 2014-10-29 | 2021-05-25 | Bicyclerd Ltd | Bicyclic peptide ligands specific for mt1-mmp |
| MA45328A (en) * | 2016-04-01 | 2019-02-06 | Avidity Biosciences Llc | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF |
| JP2019523630A (en) * | 2016-04-22 | 2019-08-29 | アリゲーター・バイオサイエンス・アーベー | Novel bispecific polypeptide for CD137 |
| EP3661948B1 (en) | 2017-08-04 | 2022-06-01 | BicycleTx Limited | Bicyclic peptide ligands specific for cd137 |
| TWI825046B (en) | 2017-12-19 | 2023-12-11 | 英商拜西可泰克斯有限公司 | Bicyclic peptide ligands specific for epha2 |
| GB201721265D0 (en) | 2017-12-19 | 2018-01-31 | Bicyclerd Ltd | Bicyclic peptide ligands specific for EphA2 |
| BR112020014576A2 (en) | 2018-02-23 | 2020-12-08 | Bicycletx Limited | MULTIMERIC BICYCLIC PEPTIDE BINDERS |
| GB201810316D0 (en) | 2018-06-22 | 2018-08-08 | Bicyclerd Ltd | Peptide ligands for binding to EphA2 |
| US20220184222A1 (en) | 2019-04-02 | 2022-06-16 | Bicycletx Limited | Bicycle toxin conjugates and uses thereof |
| TW202110485A (en) | 2019-07-30 | 2021-03-16 | 英商拜西可泰克斯有限公司 | Heterotandem bicyclic peptide complex |
| WO2021064428A1 (en) | 2019-10-03 | 2021-04-08 | Bicycletx Limited | Heterotandem bicyclic peptide complexes |
| CN114760988A (en) | 2019-11-27 | 2022-07-15 | 拜斯科技术开发有限公司 | Bicyclic peptide ligands specific for EphA2 and uses thereof |
-
2019
- 2019-04-02 CA CA3095582A patent/CA3095582A1/en active Pending
- 2019-04-02 US US16/372,692 patent/US11453703B2/en active Active
- 2019-04-02 CN CN201980037963.XA patent/CN112236442A/en active Pending
- 2019-04-02 AU AU2019247795A patent/AU2019247795A1/en active Pending
- 2019-04-02 BR BR112020020349-1A patent/BR112020020349A2/en unknown
- 2019-04-02 EP EP19717554.0A patent/EP3774851A1/en active Pending
- 2019-04-02 WO PCT/GB2019/050951 patent/WO2019193328A1/en unknown
- 2019-04-02 MX MX2020010444A patent/MX2020010444A/en unknown
- 2019-04-02 SG SG11202009773VA patent/SG11202009773VA/en unknown
- 2019-04-02 JP JP2020554265A patent/JP2021520378A/en active Pending
- 2019-04-02 KR KR1020207031802A patent/KR20200139236A/en unknown
-
2020
- 2020-10-01 IL IL277717A patent/IL277717A/en unknown
-
2022
- 2022-05-12 US US17/663,169 patent/US20230008076A1/en active Pending
-
2024
- 2024-02-05 JP JP2024015762A patent/JP2024062998A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020020349A2 (en) | 2021-01-05 |
| JP2024062998A (en) | 2024-05-10 |
| CN112236442A (en) | 2021-01-15 |
| US20190307836A1 (en) | 2019-10-10 |
| EP3774851A1 (en) | 2021-02-17 |
| AU2019247795A1 (en) | 2020-11-12 |
| KR20200139236A (en) | 2020-12-11 |
| CA3095582A1 (en) | 2019-10-10 |
| JP2021520378A (en) | 2021-08-19 |
| US20210299210A2 (en) | 2021-09-30 |
| WO2019193328A1 (en) | 2019-10-10 |
| MX2020010444A (en) | 2021-01-08 |
| IL277717A (en) | 2020-11-30 |
| US11453703B2 (en) | 2022-09-27 |
| US20230008076A1 (en) | 2023-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277717A (en) | Heterotandem bicyclic peptide complexes | |
| IL290089A (en) | Heterotandem bicyclic peptide complexes | |
| ZA202100442B (en) | Bicyclic peptide ligands specific for nectin-4 | |
| IL276803A (en) | Multimeric bicyclic peptide ligands | |
| IL275440A (en) | Bicyclic peptide ligands specific for epha2 | |
| GB201721265D0 (en) | Bicyclic peptide ligands specific for EphA2 | |
| GB201820316D0 (en) | Bicyclic peptide ligands specific for IL-17 | |
| GB201820320D0 (en) | Bicyclic peptide ligands specific for FAPalpha | |
| GB201820981D0 (en) | Heterotandem bicyclic peptide complexes | |
| GB201805492D0 (en) | Heterotandem Bicyclic peptide complexes | |
| GB201818499D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201815684D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201818158D0 (en) | Multimeric bicyclic peptide ligands | |
| GB201720934D0 (en) | Bicyclic peptide ligands specific for FAPalpha | |
| GB201805848D0 (en) | Multimeric bicyclic peptide ligands | |
| GB201820322D0 (en) | Bicyclic peptide ligands specific for TGFbeta | |
| GB201918495D0 (en) | Bicyclic peptide ligands specific for il-46 | |
| GB201802931D0 (en) | Multimeric bicyclic peptide ligands | |
| GB201712693D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201820313D0 (en) | Bicyclic peptide ligands specific for KLK5 | |
| GB201820310D0 (en) | Bicyclic peptide ligands specific for Hsp90 | |
| GB201904632D0 (en) | Bicyclic peptide ligands specific for nectin-4 | |
| GB201820314D0 (en) | Bicyclic peptide ligands specific for KLK7 | |
| GB201720927D0 (en) | Bicyclic peptide ligands specific for HSP90 | |
| GB201820326D0 (en) | Bicyclic peptide ligands specific for epha3 |